In response to COVID-19, Gynuity recently led the collaborative development of a sample protocol for providing medication abortion without any routine facility-based tests either before or after treatment. The protocol includes recommendations for patient selection, Rh status evaluation and management, the treatment regimen, and follow-up without facility-based tests.
No-Test Medication Abortion: A Sample Protocol for Increasing Access During a Pandemic and Beyond